Hygrothermal Performance of Salt (NaCl) for Internal Surface Applications in the Building Envelope

Salt (NaCl), as a by-product from the potash and desalination industry, can be the solution to the scarcity of building materials and might replace more energy-consuming materials. However, salt carries the risk of deliquescence in humid environments. This study conducted fundamental research on the hygrothermal performance of salt for internal surface applications in the building envelope in six different climate conditions. In addition, salt’s performance was also compared with that of gypsum in similar applications. The simulation models (using WUFI^®Pro, WUFI^®Plus) and in situ measurements were applied to investigate the hygrothermal consequences of the incorporation of salt on the thermal envelope, indoor environment, and energy consumption. Our studies revealed that salt provided the best hygrothermal responses without Heating, Ventilation, and Air Conditioning (HVAC) in very hot-dry and the worst in very hot-humid climates. With an energy-efficient thermal envelope and HVAC, salt can also find an indoor application in temperate, continental, and subpolar climates. In comparison to gypsum, salt has a slightly higher energy demand (heating, cooling, and dehumidification) due to its higher thermal conductivity and moisture resistance. This study fills the knowledge gap on salt’s hygrothermal performance and shows the potential in its utilization.     

Molecular characterization of commercial porcine factor VIII concentrate

Commercial porcine factor VIII concentrate (Hyate:C) is effective in treatment of patients with hemophilia A who have circulating antibodies to factor VIII. The molecular forms of factor VIII in the concentrate were identified and evaluated in light of the known properties of porcine and human factor VIII. The factor VIII in the concentrate was isolated by tandem chromatography on gelatin-Sepharose and monoclonal anti-factor VIII-Sepharose. The factor VIII was 1% of the protein mass of the concentrate when calculated by either quantity of protein recovered or by radioimmunoassay. Both functional assay and Western blotting of the crude concentrate indicated that maximum coagulant function was achieved by proteolytic activation of procofactor forms of factor VIII. The factor VIII can be fractionated by cation-exchange high-performance liquid chromatography (HPLC) into two or three species of heterodimers depending on the lot. The specific activity of the purified porcine factor VIII was 550 U/mg using pooled porcine plasma at 1 U/mL as a standard. From this value, a factor VIII concentration in normal pig plasma of 2 micrograms/mL was calculated. This agreed well with a value of 3 micrograms/mL obtained by radioimmunoassay (RIA) of factor VIII in porcine plasma. In contrast, reported values for human factor VIII average 5800 U/mg, resulting in a calculated concentration in plasma of 0.2 microgram/mL. The finding that porcine plasma contains a significantly higher circulating mass of factor VIII than human plasma appears to explain previous difficulties in comparing porcine and human factor VIII in standard assays.     

新抗胆碱药[3H]三环哌酯对人脑M受体的作用

用放射配体受体结合试验法,研究了新化合物三环哌酯与人大脑皮质M受体的结合特性,并与QNB作了比较。饱和实验结果显示,[³H]三环哌酯的结合参数与[³H]QNB相近,两种配体的作用均符合单位点模型。竞争性抑制实验结果表明二者作用强度相当。[³H]三环哌酯的结合和解离速率常数均较[³H]QNB大,且其与皮质M受体的解离受季铵酚的变构调节,结果提示,两种配体与M受体有一些不同的结合特性,在M受体研究中,[³H]三环哌酯可以作为[³H]QNB的补充工具。     

Size specificity and interocular suppression: Monocular evoked potentials and reaction times

Changes in visual evoked potentials (VEPs) and reaction time (RT) to checkerboards flashed to the left eye were investigated as a function of the size of checks in checkerboards continuously viewed by the right eye. The checkerboards, ranging in check size from 9′ to 95′ of arc, were presented to corresponding retinal areas by means of a haploscope. The results indicated that continuous stimulation of one eye suppressed VEP amplitude in response to flashing the other eye. The interocular suppression was size specific: VEP amplitude became progressively smaller as the check size of the suppressing stimulus approached that of the test stimulus (12′ or 35′ of arc) and was smallest when both eyes were stimulated by the same check size. Interocular suppression was reflected to a lesser degree in the RT data. The results are consistent with the hypotheses that there are binocularly innervated size-specific channels located central to the optic chiasm and that saturation of such a channel by continuous stimulation of one eye, with the appropriate check size, will occlude responsivity of that channel to transient stimulation of the other eye.     

Growth of the uterus

BACKGROUND: The pattern of growth of the uterus was examined by ultrasound examinations of 358 girls who attended a paediatric endocrine outpatient department but were shown not to have any endocrine defect. METHOD: The uterus was measured in length and width at the cervix and at the fundus (cm). Endometrial thickness was measured (mm). Scans were divided by Tanner breast stage and the dimensions compared by one way analysis of variance (ANOVA, with the Student Newman Keuls post hoc test). RESULTS: There was an increase in uterine length, diameter of the fundus, and endometrial thickness at each breast stage from 1 to 5 (ANOVA, p < 0.05), and in the diameter of the cervix with each breast stage from 1 to 4 (ANOVA, p < 0.05). The ratio of the fundus to the cervix increased from 0.95 to 1.29 between breast stages 1 and 4. CONCLUSION: The onset of puberty is marked by an increase in the dimensions of the uterus and in endometrial thickness, but also by a change in the shape of the uterus from a tubular to a pear shaped organ.     

Morphine-induced TSH release in normal and hypothyroid subjects

The effects of morphine (10 mg i.v.), an opioid agonist, and of naloxone (10 mg i.v.), an opioid antagonist, on serum levels of TSH and PRL were studied in 7 hypothyroid patients and in 5 normal volunteers. Morphine administration induced a prompt, significant increase in serum TSH and PRL in all subjects. The degree of PRL release after morphine was similar in the two groups, while, as regards TSH, the increase was more evident in hypothyroid subjects. Pretreatment with naloxone (4 mg i.v. 5 min before morphine administration) blocked these effects in all subjects. In contrast, naloxone alone was not able to affect significantly TSH and PRL secretion. Moreover, in 5 other euthyroid volunteers, morphine significantly enhanced the response of TSH and PRL to TRH stimulation (200 micrograms i.v.). These data demonstrate that morphine exerts a stimulatory action on TSH and PRL secretion: the possible mode of action of this drug and the physiologic significance of these findings are discussed.